未经证实:Graves病的患病率在所有甲状腺功能亢进症的21%至80%之间差异很大。2018年在泗水Soetomo地区总医院进行的研究发现,在所有甲状腺功能亢进病例中,有多达66.7%的人患有格雷夫斯病。周期性麻痹(TPP)是一种以可逆性肌肉无力和瘫痪为特征的疾病,伴有低钾血症,通常伴随着甲状腺功能亢进,主要是由格雷夫斯病引起的。TPP中严重低钾血症的管理具有挑战性。
未经批准:男性,29岁的患者抱怨在来医院急诊科之前的最后6小时内,双腿小腿感到虚弱。该患者于2018年被诊断为甲状腺功能亢进。发现了一个细微的震颤,患者入院4天,并在内分泌综合诊所常规控制。
UASSIGNED:在进行治疗之前,必须确定甲状腺毒症的潜在疾病或病因。进行钾替代疗法时的主要关注点是反弹高钾血症的发生,因为这种低钾血症不是由总钾消耗引起的。
未经评估:甲状腺毒症周期性麻痹的治疗原则是正确的诊断,排除瘫痪的其他原因,低钾血症的其他原因,缓慢和逐渐纠正低钾血症,密切而仔细的临床监测,心电图,和实验室。
UNASSIGNED: The prevalence of Graves\' disease varies widely between 21 and 80% of all cases of hyperthyroidism. Research conducted in 2018 at the Dr. Soetomo Regional General Hospital Surabaya found Graves\' disease in as many as 66.7% of all cases of hyperthyroidism. Thyrotoxicosis Periodic Paralysis (TPP) is a disorder characterized by reversible muscle weakness and paralysis, accompanied by hypokalemia, which usually accompanies hyperthyroidism, mostly caused by Graves\' disease. Management of severe hypokalemia in TPP is challenging.
UNASSIGNED: male, 29 years patient complained that both lower legs felt weak in the last 6 hours before coming to the hospital emergency department. The patient was diagnosed with hyperthyroidism in 2018. A fine tremor was found, and the patient was admitted to the hospital for 4 days and routinely controlled at the endocrine polyclinic.
UNASSIGNED: The underlying disease or causative etiology of thyrotoxicosis must be determined before treatment is conducted. The main concern when performing potassium replacement therapy is the occurrence of rebound hyperkalemia because this hypokalemia condition is caused not by total potassium depletion.
UNASSIGNED: The principles of management for thyrotoxicosis periodic paralysis are proper diagnosis, exclusion of other causes of paralysis, and other causes of hypokalemia, slow and gradual correction of hypokalemia, and close and careful clinical monitoring, ECG, and laboratory.